Tshiyoyo, Kadima SamuelBester, Megan JeanSerem, June CheptooApostolides, Zeno2023-02-172022-10Tshiyoyo, K.S., Bester, M.J., Serem, J.C. et al. 2022, 'In-silico reverse docking and in-vitro studies identified curcumin, 18α-glycyrrhetinic acid, rosmarinic acid, and quercetin as inhibitors of α-glucosidase and pancreatic α-amylase and lipid accumulation in HepG2 cells, important type 2 diabetes targets', Journal of Molecular Structure, vol. 1266, art. 133492, pp. 1-10, doi : 10.1016/j.molstruc.2022.133492.0022-2860 (print)1872-8014 (online)10.1016/j.molstruc.2022.133492https://repository.up.ac.za/handle/2263/89650Please read abstract in the article.en© 2022 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Journal of Molecular Structure. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Journal of Molecular Structure, vol. 1266, art. 133492, pp. 1-10, doi : 10.1016/j.molstruc.2022.133492.α-amylaseα-glucosidaseHerbal compoundsHepatic lipid accumulationIn-vitro cytotoxicityReverse molecular dockingType 2 diabetes mellitus (T2DM)Health sciences articles SDG-03SDG-03: Good health and well-beingPostprint Article